PHASTAR Enters Partnership with Medidata
PHASTAR announced that it has entered into a technology partnership with Medidata Solutions, Inc. PHASTAR will deploy several solutions from the Medidata Rave Clinical Cloud including Rave EDC, Coder, eCOA, and RTSM.
The adoption of the Medidata Rave Clinical Cloud comes as PHASTAR continues to grow its market share in data services. PHASTAR has expanded its Data Operations teams in Kenya and the UK to provide professional services, and, with the opening of its second U.S. office in Boston, its partnership with Medidata will further power its U.S. expansion.
PHASTAR understands that Medidata is an innovative partner that provides technology for servicing data studies, along with transformative and collaborative solutions to help PHASTAR support emerging techniques.
“We are excited to partner with PHASTAR in its mission to support the pharmaceutical and biotech sector in safely bringing new therapies and medical devices to patients,” said Glen de Vries, co-founder and president, Medidata. “Our unified platform will enable PHASTAR to design and conduct complex clinical trials, and turn large volumes of data into insights."
Andrew MacGarvey, Managing Director, PHASTAR, said, “I am pleased to expand our offering following the addition of the Medidata platform to our technology solutions. Our Data Operations team deliver excellent services across the world and Medidata will allow the team to service projects more efficiently as they work within the unified platform. Our new Data Sciences group is developing tools and techniques to help our customers maximise the data they collect. Medidata understand that the types of data collected during clinical trials are changing and the amount of data underpinning clinical research is increasing extremely quickly. We hope to work closely with their team as our customer needs evolve over the coming years.”
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
